Ferretab comp., 30 pcs.

Ferrethab comp. – is a remedy for the treatment and prevention of iron deficiency conditions.

The action is determined by the properties of its constituent active ingredients.

Iron fumarate is a salt of iron, a trace element necessary for the synthesis of hemoglobin. When iron is used in the form of salts it is quickly replenished in the body, which leads to gradual regression of clinical (weakness, fatigue, dizziness, tachycardia, soreness and dry skin) and laboratory symptoms of anemia.

Folic acid is necessary for normal maturation of megaloblasts and formation of normoblasts. It stimulates erythropoiesis, is involved in the synthesis of amino acids, nucleic acids, purines and pyrimidines, choline metabolism. During pregnancy it protects the body from teratogenic factors.

In serum iron is bound to transferrin, is involved in the formation of hemoglobin, myoglobin, cytochrome oxidase, catalase and peroxidase or stored in body tissues as ferritin.

Pharmacokinetics

The excretion of iron occurs with feces, urine and sweat.

Folic acid is absorbed mainly in the upper intestine (duodenum) and is 64% bound to proteins. It is metabolized in the liver and excreted mainly through the kidneys and partially with the feces.

Indications

Treatment of latent iron deficiency and iron deficiency anemia with folic acid deficiency, especially during pregnancy.

Pharmacological effect

Pharmacotherapeutic group: antianemic drugs, iron in combination with folic acid.

Pharmacological properties: Ferretab comp contains the active ingredient iron (II) fumarate in the form of mini-tablets with a delayed release of the active substance, which avoids high local concentrations of iron, which can irritate the mucous membranes.

Folic acid is central to the intermediary metabolism of all living cells.

Special instructions

Precautions: To avoid the risk of iron overdose, extreme caution should be used when using dietary or other supplements containing iron salts. Primary anemia should be excluded before treatment with folic acid.

Active ingredient

Ferrous fumarate, Folic acid

Composition

Active ingredient:

iron (II) fumarate – 152.10 mg (equivalent to Fe(II) 50 mg);
folic acid – 0.50 mg.
Excipients: lactose monohydrate, methyl acrylate and ethyl acrylate copolymer [2: 1], colloidal silicon dioxide, magnesium stearate, microcrystalline cellulose, azorubine dye, quinoline yellow dye, titanium dioxide, gelatin.

Pregnancy

Ferretab comp is suitable for use during pregnancy and lactation.

Contraindications

Hypersensitivity to the active components or to any of the auxiliary components of the drug; current status of diseases associated with impaired iron accumulation: hemochromatosis, hemosiderosis, chronic hemolysis; disorders of iron absorption: sideroachrestic anemia, thalassemia, lead anemia; hemoglobinopathies, hemolytic anemia, aplastic anemia, pernicious anemia, anemia not caused by iron and folic acid deficiency, gastrointestinal disorders.

Side Effects

Iron therapy may predispose to paroxysmal nocturnal hemoglobinuria, erythropoietic porphyria or porphyria cutanea tarda (very rare). Iron may cause allergic skin reactions (rare). Folic acid may cause allergic reactions such as erythema, itching, bronchospasm, nausea or anaphylactic shock (very rare).

Storage conditions

In a place protected from light, at a temperature not exceeding 25°C.

Shelf life

3 years.

Manufacturer

G.L.Pharma GmbH, Austria